Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Nivolumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Ono Pharmaceutical
Bristol-Myers Squibb
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection 4mL
Injection 10mL
Application:
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Nivolumab Industry Overview
-
1.1.1 Nivolumab Market Scope and Market Segments
-
1.1.2 Nivolumab Industry Characteristics
-
1.1.3 Global and China Nivolumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Nivolumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Nivolumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection 4mL
-
1.2.2 Injection 10mL
-
1.3 Global Nivolumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Unresectable Melanoma
-
1.3.2 Metastatic Melanoma
-
1.3.3 Metastatic Squamous NSCLC
-
1.3.4 Classical Hodgkin Lymphoma
-
1.3.5 Renal Cell Carcinoma
-
1.3.6 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Nivolumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Nivolumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Nivolumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Nivolumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Nivolumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Nivolumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Nivolumab Industry PEST Analysis
-
2.3 Nivolumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Nivolumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Nivolumab Industry
Chapter 3 Global and China Nivolumab Market, by Manufacturer
-
3.1 Global and China Nivolumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Nivolumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Nivolumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Nivolumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Nivolumab Market Top 3 Players
Chapter 4 Global and China Nivolumab Market, by Type (2017-2028)
-
4.1 Nivolumab Market Trend, by Type
-
4.2 Global Nivolumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Nivolumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Nivolumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Nivolumab Price Trend, by Type (2017-2028)
-
4.3 China Nivolumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Nivolumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Nivolumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Nivolumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Nivolumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Nivolumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Nivolumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Nivolumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Nivolumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Nivolumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Nivolumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Nivolumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Nivolumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Nivolumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Nivolumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Nivolumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Nivolumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Nivolumab Market Analysis
-
7.1 North America Nivolumab Market, by Type
-
7.2 North America Nivolumab Market, by Application
-
7.3 North America Nivolumab Market Analysis and Forecast, by Country
-
7.3.1 United States Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Nivolumab Market Analysis
-
8.1 Europe Nivolumab Market, by Type
-
8.2 Europe Nivolumab Market, by Application
-
8.3 Europe Nivolumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Nivolumab Market Analysis
-
9.1 APAC Nivolumab Market, by Type
-
9.2 APAC Nivolumab Market, by Application
-
9.3 APAC Nivolumab Market Analysis and Forecast, by Country
-
9.3.1 China Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Nivolumab Market Analysis
-
10.1 Latin America, Middle East and Africa Nivolumab Market, by Type
-
10.2 Latin America, Middle East and Africa Nivolumab Market, by Application
-
10.3 Latin America, Middle East and Africa Nivolumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Nivolumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Nivolumab Company Profiles
-
11.1 Ono Pharmaceutical
-
11.1.1 Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Ono Pharmaceutical Nivolumab Product Profiles, Application and Specification
-
11.1.3 Ono Pharmaceutical Nivolumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Bristol-Myers Squibb
-
11.2.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Bristol-Myers Squibb Nivolumab Product Profiles, Application and Specification
-
11.2.3 Bristol-Myers Squibb Nivolumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Nivolumab Industry Investment Prospect and Risk Assessment
-
12.1 Nivolumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Nivolumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Nivolumab Production Value and Growth Rate (2017-2028)
-
Figure China Nivolumab Production Value and Growth Rate (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Injection 4mL (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Injection 10mL (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Unresectable Melanoma (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Metastatic Melanoma (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Metastatic Squamous NSCLC (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Classical Hodgkin Lymphoma (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Renal Cell Carcinoma (2017-2028)
-
Figure Global Nivolumab Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Nivolumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Nivolumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Nivolumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Nivolumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Nivolumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Nivolumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Nivolumab Market Share, by Manufacturer in 2021
-
Figure Global and China Nivolumab Market Share, by Manufacturer in 2022
-
Table Global Nivolumab Sales Volume, by Type (2017-2028)
-
Table Global Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table Global Nivolumab Sales Value, by Type (2017-2028)
-
Table Global Nivolumab Sales Value Share, by Type (2017-2028)
-
Figure Global Nivolumab Price Trend, by Type (2017-2028)
-
Table China Nivolumab Sales Volume, by Type (2017-2028)
-
Table China Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure China Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table China Nivolumab Sales Value, by Type (2017-2028)
-
Table China Nivolumab Sales Value Share, by Type (2017-2028)
-
Figure China Nivolumab Price Trend, by Type (2017-2028)
-
Table Global Nivolumab Sales Volume, by Application (2017-2028)
-
Table Global Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Nivolumab Sales Volume Share, by Application (2017-2028)
-
Table Global Nivolumab Sales Value, by Application (2017-2028)
-
Table Global Nivolumab Sales Value Share, by Application (2017-2028)
-
Figure Global Nivolumab Sales Value Share, by Application (2017-2028)
-
Table China Nivolumab Sales Volume, by Application (2017-2028)
-
Table China Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure China Nivolumab Sales Volume Share, by Application (2017-2028)
-
Table China Nivolumab Sales Value, by Application (2017-2028)
-
Table China Nivolumab Sales Value Share, by Application (2017-2028)
-
Figure China Nivolumab Sales Value Share, by Application (2017-2028)
-
Figure China Nivolumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Nivolumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Nivolumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Nivolumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Nivolumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Nivolumab Sales Volume, by Type (2017-2028)
-
Table North America Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table North America Nivolumab Sales Volume, by Application (2017-2028)
-
Table North America Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Nivolumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Nivolumab Sales Volume, by Type (2017-2028)
-
Table Europe Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Nivolumab Sales Volume, by Application (2017-2028)
-
Table Europe Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure France Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Nivolumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Nivolumab Sales Volume, by Type (2017-2028)
-
Table APAC Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Nivolumab Sales Volume, by Application (2017-2028)
-
Table APAC Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure China Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure India Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Nivolumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Nivolumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Nivolumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Nivolumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Nivolumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Nivolumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Nivolumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Nivolumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Nivolumab Sales Value and Growth Rate (2017-2028)
-
Table Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ono Pharmaceutical Product Profiles, Application and Specification
-
Table Ono Pharmaceutical Nivolumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Nivolumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
